Literature DB >> 2151115

The use of transgenic mice for short-term, in vivo mutagenicity testing.

S W Kohler1, G S Provost, P L Kretz, A Fieck, J A Sorge, J M Short.   

Abstract

In order to develop a short-term, in vivo assay to study the mutagenic effects of chemical exposure, transgenic mice were generated using a lambda shuttle vector containing a lacZ target gene. Following exposure to mutagens, this target can be rescued efficiently from genomic DNA prepared from tissues of the treated mice using restriction minus, in vitro lambda phage packaging extract and restriction minus Escherichia coli plating cultures. Mutations in the target gene appear as colorless plaques on a background of blue plaques when plated on indicator agar. Spontaneous background levels were approximately 1 x 10(-5) in each of three mouse lineages analyzed. Exposure of lambda transgenic mice to N-ethyl-N-nitrosourea resulted in as much as a 14-fold induction in detected mutations over background levels. The assay is currently being modified to incorporate lacI as the target for ease of mutation detection as well as in vivo excision properties of the Lambda ZAP vector, facilitating sequence analysis of mutant plaques.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151115     DOI: 10.1016/0735-0651(90)90003-x

Source DB:  PubMed          Journal:  Genet Anal Tech Appl        ISSN: 1050-3862


  11 in total

1.  Proliferation is necessary for both repair and mutation in transgenic mouse cells.

Authors:  J H Bielas; J A Heddle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.

Authors:  S E Andrew; M McKinnon; B S Cheng; A Francis; J Penney; A H Reitmair; T W Mak; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 3.  Past, Present and Future Directions of gpt delta Rodent Gene Mutation Assays.

Authors:  Takehiko Nohmi
Journal:  Food Saf (Tokyo)       Date:  2016-03-30

4.  Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.

Authors:  Charles R Madden; Milton J Finegold; Betty L Slagle
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy.

Authors:  Sho Ueda; Satoshi Yamashita; Miho Nakajima; Tadashi Kumamoto; Chitose Ogawa; Yu-Yu Liu; Harumi Yamada; Emi Kubo; Naoko Hattori; Hideyuki Takeshima; Mika Wakabayashi; Naoko Iida; Yuichi Shiraishi; Masayuki Noguchi; Yukio Sato; Toshikazu Ushijima
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-27       Impact factor: 12.779

Review 6.  Reporter genes in transgenic mice.

Authors:  C Cui; M A Wani; D Wight; J Kopchick; P J Stambrook
Journal:  Transgenic Res       Date:  1994-05       Impact factor: 2.788

7.  Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.

Authors:  J L Jakubczak; G Merlino; J E French; W J Muller; B Paul; S Adhya; S Garges
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

8.  Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability.

Authors:  A Baross-Francis; S E Andrew; J E Penney; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.

Authors:  S W Kohler; G S Provost; A Fieck; P L Kretz; W O Bullock; J A Sorge; D L Putman; J M Short
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.

Authors:  M L Cunningham; J J Hayward; B S Shane; K R Tindall
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.